Ariel Investments, the firm founded by prominent value investor John Rogers, has initiated a new position in Haemonetics Corp. (HAE), a global medical technology company. According to its latest quarterly disclosure, Ariel purchased 2.06 million shares, a stake valued at approximately $154.57 million which represents 1.54% of its reported portfolio.
This investment was revealed in a 13F filing, which discloses positions held as of June 30, 2026, meaning the trades occurred in the second quarter. Haemonetics specializes in products for blood and plasma collection and hospital transfusion services. The company's technologies are utilized in blood banks, hospitals, and plasma collection centers worldwide.